This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $98,525.67 firm fixed-price delivery order is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty medication.
The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This order falls under that IDC. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen is the prime contractor, and there are no subcontractors mentioned. The DLA, a defense agency, is the funding agency for this award, which supports military and veterans' healthcare needs.
Generated 3/18/25, 9:50 AM